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Abstract
Multifunctional trans-cinnamaldehyde (CA) and its analogs display anti-cancer properties, with 2-benzoyloxycinnamalde-
hyde (BCA) and 5-fluoro-2-hydroxycinnamaldehyde (FHCA) being identified as the ortho-substituted analogs that possess
potent anti-tumor activities. In this study, BCA, FHCA and a novel analog 5-fluoro-2-benzoyloxycinnamaldehyde (FBCA),
were demonstrated to decrease growth and colony formation of human colon-derived HCT 116 and mammary-derived
MCF-7 carcinoma cells under non-adhesive conditions. The 2-benzoyloxy and 5-fluoro substituents rendered FBCA more
potent than BCA and equipotent to FHCA. The cellular events by which these cinnamaldehydes caused G2/M phase arrest
and halted proliferation of HCT 116 cells were thereby investigated. Lack of significant accumulation of mitosis marker
phospho-histone H3 in cinnamaldehyde-treated cells indicated that the analogs arrested cells in G2 phase. G2 arrest was
brought about partly by cinnamaldehyde-mediated depletion of cell cycle proteins involved in regulating G2 to M transition
and spindle assembly, namely cdk1, cdc25C, mad2, cdc20 and survivin. Cyclin B1 levels were found to be increased, which in
the absence of active cdk1, would fail to drive cells into M phase. Concentrations of cinnamaldehydes that brought about
dysregulation of levels of cell cycle proteins also caused tubulin aggregation, as evident from immunodetection of dose-
dependent tubulin accumulation in the insoluble cell lysate fractions. In a cell-free system, reduced biotin-conjugated
iodoacetamide (BIAM) labeling of tubulin protein pretreated with cinnamaldehydes was indicative of drug interaction with
the sulfhydryl groups in tubulin. In conclusion, cinnamaldehydes treatment at proapoptotic concentrations caused tubulin
aggregation and dysegulation of cell cycle regulatory proteins cdk1 and cdc25C that contributed at least in part to arresting
cells at G2 phase, resulting in apoptotic cell death characterized by emergence of cleaved forms of caspase 3 and poly (ADP-
ribose) polymerase (PARP). Results presented in this study have thus provided further insights into the intricate network of
cellular events by which cinnamaldehydes induce tumor cell death.
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Introduction
The cell cycle is tightly regulated by checkpoints which ensure
sequential progression through all the phases. If certain critical
events in a phase cannot be executed, these checkpoints activate
a ‘‘wait’’ signal causing cell cycle arrest until the events are
completed as programmed. However, if the normal cell cycle
cannot be restored, apoptotic pathways are activated [1].
Cancerous cells usually exhibit high growth rates because of
deregulation of cell cycle and apoptotic signaling pathways [2].
For this reason, induction of cell cycle arrest is considered as
a rational strategy to propel tumor cells into apoptosis [3].
Tubulin monomers polymerize to form microtubules that
comprise an essential part of the cytoskeleton. At the onset of
mitosis, the interphase microtubular network metamorphoses into
the mitotic spindle that faithfully segregates the two pairs of
chromosomes into daughter cells [4]. Microtubule dynamics are
crucial for spindle formation, and its inhibition may trigger
induction of apoptosis [5]. Certain clinically used anti-cancer
agents cause suppression of microtubule dynamics either by
reducing polymerization (e.g. vinblastine) or by excessive poly-
merization (e.g. paclitaxel), thus driving the cell into apoptosis
[6,7].
Trans-cinnamaldehyde (CA), the active component in cinna-
mon, and its structural analogs have been reported to exhibit an
array of biological activities including antiproliferative actions
against cancer cells [8–14]. Independent studies have proposed
diverse mechanisms responsible for the apoptosis inducing
properties of CA and its analogs (henceforth collectively referred
to as cinnamaldehydes) including loss of mitochondrial membrane
potential [15], inhibition of proteasomal activity [16], inhibition of
AP-1 activity [17], and production of reactive oxygen species
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[18,19]. In addition, our laboratory has recently reported in-
hibition of thioredoxin reductase as one of the mechanisms
responsible for the antiproliferative activities of cinnamaldehydes
[20]. The multi-targeting nature of cinnamaldehydes and their
yet-to-be fully defined proapoptotic activities have prompted the
constant quest for more potent derivatives and better understand-
ing of their molecular mechanisms. In this present study, a novel
analog 5-fluoro-2-benzoyloxycinnamaldehyde (FBCA), together
with 2-benzoyloxycinnamaldehyde (BCA) and 5-fluoro-2-hydro-
xycinnamaldehyde (FHCA), the two lead analogs identified from
a previous study [20], were investigated for the mechanisms
underlying their antiproliferative effects on the susceptible human-
derived colon carcinoma HCT 116 cell line. Cinnamaldehydes at
proapoptotic concentrations induced a G2/M phase arrest that
was associated with tubulin aggregation. In addition, levels of key
proteins regulating the G2/M phase including cdk1, cdc25C,
cdc20, mad2 and survivin were found to be decreased, while cyclin
B1 levels were increased. Taken together, the results indicated that
cinnamaldehydes induced tumor cell death, at least in part,
through targeting tubulin and evoking dysregulation of cell cycle
regulatory proteins. This has led to a better understanding of the
complex network of cellular events by which cinnamaldehydes halt
tumor cell proliferation, which can further aid the development of
this class of compounds as potential cancer therapeutics.
Materials and Methods
Chemicals and Materials
CA, cinnamic acid (CAC) and paclitaxel were purchased from
Sigma-Aldrich (St. Louis, MO). Pan caspase inhibitor Z-VAD-
FMK was from R&D Systems (Minneapolis, MN). The analogs
BCA and FHCA were synthesized as described previously [20].
Purified porcine brain tubulin was purchased from Cytoskeleton
(Denver, CO) and biotin-conjugated iodoacetamide (N-(Biotinoyl)-
N’-(Iodoacetyl)Ethylenediamine, BIAM) was purchased from
Molecular Probes (Invitrogen, Eugene, OR).
Chemical Synthesis
5-Fluoro-2-benzoyloxycinnamaldehyde [(E)-4-fluoro-2-(3-
oxoprop-1-en-1-yl)phenyl benzoate]. Triethylamine
(0.137 g, 1.355 mmol) was added to a solution of (E)-3-(5-fluoro-
2-hydroxyphenyl) acrylaldehyde [21] (0.150 g, 0.903 mmol) and
benzoyl chloride (0.152 g, 1.084 mmol) in dichloromethane
(7 ml). The reaction mixture was stirred at room temperature
for 30 min, followed by reaction quenching with water (20 ml) and
Figure 1. Chemical structures of cinnamaldehyde analogs and cinnamic acid (CAC).
doi:10.1371/journal.pone.0050125.g001
Table 1. Antiproliferative activities of cinnamaldehyde analogs against HCT 116, MCF-7 and MRC-5 cells.
Compounds HCT 116 MCF-7 MRC-5
Mean GI50
a
(mM)
Mean LC50
b
(mM)
Mean GI50
a
(mM)
Mean LC50
b
(mM)
Mean GI50
a
(mM)
Mean LC50
b
(mM)
CAc 9.261.4 35.0611.2 8.261.3 62.3622.8 40.465.9 86.461.7
BCAc 3.561.5 12.164.1 4.260.9 21.763.1 14.363.8 25.763.8
FHCAc 1.660.3 3.260.5 1.960.2 20.760.4 15.261.4 27.561.9
FBCA 1.260.3 2.960.1 1.960.8 9.160.6 12.761.2 24.260.8
Values are presented as means6SD from 3 independent experiments.
aGI50:50% growth inhibition concentration;
bLC50:50% lethal concentration;
cResults for HCT 116 and MCF-7 cell lines were adopted from Ref 20.
doi:10.1371/journal.pone.0050125.t001
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extraction with dichloromethane (2610 ml). The combined
organic extracts were dried over magnesium sulphate and solvent
was removed in vacuo. The residue was purified by column
chromatography with hexane/ethyl acetate (9/1) to give the
product as a white solid (0.234 g, 0.866 mmol, 96%). 1H NMR
(400MHz) d: 6.71 (d, J=8.0 Hz, 1H), 7.25 (m, 2H), 7.41 (d,
J=7.4 Hz, 1H), 7.58 (m, 3H), 7.73 (d, J=8.0 Hz, 1H), 8.25 (d,
J=8.0 Hz, 2H), 9.66 (s, 1H).
Cell Culture and Antibodies
Human-derived colon carcinoma HCT 116, breast carcinoma
MCF-7 and normal lung fibroblast MRC-5 cells were obtained
from ATCC (Rockville, MD). The two cancer cell lines and
fibroblasts were respectively maintained in RPMI 1640 and MEM
medium supplemented with 10% fetal bovine serum (FBS), 100
units/ml penicillin and 1 mg/ml streptomycin at 37uC and 5%
CO2. Antibodies against cdc25C, mad2 and b-actin were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA),
and those against caspase 3, cleaved caspase 3 (Asp 175), phospho-
cdk1 (Tyr15), cdk1, PARP/cleaved PARP, phospho-cdc25C
(Ser216), phospho-cyclin B1 (Ser133), cyclin-B1, phospho-histone
H3 (Ser10) and cdc20 were obtained from Cell Signaling
Technology (Beverly, MA), anti-survivin antibody was purchased
from Epitomics (Burlingame, CA), and monoclonal anti-b-tubulin
(T5201) antibody was from Sigma-Aldrich. Horseradish peroxi-
dase (HRP) conjugated anti-mouse and anti-rabbit secondary
antibodies were acquired from Pierce (Rockford, IL), while Alexa
Fluor 488 conjugated anti-mouse IgG and Alexa Fluor 594-
conjugated anti-rabbit IgG were purchased from Molecular
Probes.
Cell Viability Assay
The effect of cinnamaldehydes on cell viability was assessed by
viable cell-mediated reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT). HCT116, MCF-7 and
MRC-5 cells were seeded in 96-well plates at a density of
36103, 46103 and 66103 per well respectively, allowed to attach
for around 24–36 h to reach approximately 60% confluence, and
treated with drugs. Drug solutions in medium were freshly
prepared from drug stocks in DMSO before treatment. After
72 h of drug treatment, MTT (400 mg/ml) was added into each
well and plates were incubated for another 4 h. Medium and
MTT from the wells was aspirated, the purple formazan crystals
were dissolved in a DMSO:Glycine buffer pH 10.5 (4:1) mixture
and absorbance was read at 550 nm.
Soft Agar Assay
HCT 116 (36104) or MCF-7 (56104) cells were suspended in
RPMI 1640 medium containing 0.33% w/v low melting agarose,
10% FBS, as well as DMSO or different concentrations of
Figure 2. Effect of cinnamaldehydes on anchorage-independent growth of HCT 116 and MCF-7 cells. Cell suspensions prepared in RPMI
1640 agarose medium containing DMSO, CAC or different concentrations of cinnamaldehydes were layered onto a pre-solidified agarose medium in
each well of 6-well plates. The cultures were incubated at 37uC for two weeks and cell colonies greater than 0.1 mm were counted manually using
a light microscope. Left panel: representative photomicrographs (106magnification) illuminating the effects of cinnamaldehydes on the anchorage-
independent growth of HCT 116 and MCF-7 cells. Right panel: Bar graphs showing reduction in number of cell colonies. *p,0.05, **p,0.01 versus
DMSO control.
doi:10.1371/journal.pone.0050125.g002
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Figure 3. Effect of cinnamaldehydes on cell cycle progression of HCT 116 cells. (a) Representative DNA histograms of cells following
treatment with indicated concentrations of CA, BCA, FHCA or FBCA at timepoints as indicated. (b) Percentages of cells in sub G1 and G2/M phases
after exposure to CA, BCA, FHCA or FBCA. Data points are means6SD of three independent experiments. (c) Cells were treated with cinnamaldehydes
at indicated concentrations for 12 h. Cell lysates were analyzed by Western blotting for phospho-histone H3 (p-histone H3). (d) Upper panel:
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cinnamaldehydes. The cell suspensions were then layered onto
a bottom layer of RPMI 1640 medium containing 0.5% agarose
and 10% FBS pre-solidified in each well of six-well plates. The
cells were incubated at 37uC in a humidified atmosphere
containing 5% CO2 for 2 weeks, after which cell colonies of size
bigger than 0.1 mm were enumerated at 10x magnification using
a Nikon Eclipse TE2000-U microscope (Tokyo, Japan). Repre-
sentative photomicrographs were taken using a Nikon Digital
Camera DXM1200 connected to the microscope.
Cell Cycle Analysis
HCT 116 cells were seeded in six-well plates at a density of
56105 cells per well and incubated for 24 h before drug treatment.
Following drug treatment, floating and attached cells were
collected at pre-determined timepoints, washed with cold PBS
and incubated overnight in 500 ml hypotonic fluorochrome
solution [50 mg/ml propidium iodide (PI), 0.1% sodium citrate,
0.1% Triton X-100, and 0.1 mg/ml RNase A] at 4uC protected
from light. Samples were then analyzed on a Beckman Coulter
(Dako) CyAn ADP flow cytometer and data analysis was
performed using Summit Software v4.3.
Immunocytochemistry
HCT 116 cells (56105) were cultured on coverslips (pre-coated
with 0.01% w/v poly-L-lysine) placed in individual wells of six-well
plates. After overnight incubation, cells were treated with drugs for
12 h, and fixed with 4% paraformaldehyde. Fixed cells were
permeabilized using 2% Triton X-100 in PBS, followed by
blocking with 5% horse serum, then probed with anti-phospho-
histone H3 antibody followed by Alexa Fluor 594-conjugated anti-
rabbit IgG or anti-b-tubulin antibody followed by Alexa Fluor
488-conjugated anti-mouse IgG. The immunolabeled coverslips
were mounted on glass slides using Vectashield mounting medium
with 49,6-diamidino-2-phenylindole (DAPI; Vectorlabs, Burlin-
game, CA). Microscopic images were obtained using a Nikon
Eclipse Ti-S epifluorescence microscope connected to a Nikon DS-
Ri1 camera. To quantify cells stained by anti-phospho-histone H3
antibody, results were expressed as a percentage of cells co-labelled
with DAPI and Alexa Fluor 594 over cells stained with DAPI in
a total of 6 microscopic images (406magnification) taken from
random spots on the immunolabelled coverslips. Results were
representative of three independent experiments.
Cell Lysate Preparation for Western Blot Analysis of Cell
Cycle Regulatory Proteins
HCT 116 cells (1.56106) were cultured on 100 mm plates and
incubated for 24 h to allow attachment and exponential growth
before treatment with cinnamaldehydes. Adherent and floating
cells were pelleted, washed with cold PBS and lysed in Triton X-
100 lysis buffer. Protein contents were determined by modified
Bradford assay.
Western Blot Analysis
Cell lysates or their fractions containing equal amounts of
protein (30 mg) were resolved by SDS-PAGE (10–15% gels) and
transferred to nitrocellulose membranes (Bio-Rad laboratories,
Hercules, CA). Membranes were probed with primary antibody
followed by secondary antibody conjugated to HRP, and then
developed using enhanced chemiluminescence system [Super-
Signal West Femto, (Pierce) or Western Lightning Plus, Perki-
nElmer (Boston, MA)]. All blots are representative of at least two
independent experiments.
Cell Lysate Preparation for Separation of Soluble and
Insoluble Tubulin Fractions
HCT 116 cells were seeded on 60 mm plates at a density of
76105 cells per plate and allowed to attach for 24 h before drug
treatment. Following drug treatment (16 h), cells were lysed in
Triton X-100 lysis buffer (25 mM Tris-HCl pH 7.5, 100 mM
NaCl, 2.5 mM EGTA, 2.5 mM EDTA, 20 mM NaF, 1 mM
Na3VO4, 10 mM sodium pyrophosphate, 20 mM sodium b-
glycerophosphate, 0.5% Triton X-100) containing freshly added
protease inhibitor cocktail (Roche Diagnostics, Mannheim,
Germany) and the lysates were centrifuged at 13000 rpm for
10 min at 4uC. Supernatant was separated and the pellet was
solubilized in SDS lysis buffer (65 mM Tris-HCl pH 7.5, 150 mM
NaCl, 2% SDS) before sonication. The supernatant was defined as
the soluble tubulin fraction and the solubilized pellet was defined
as the insoluble tubulin fraction. Protein contents of the soluble
tubulin fractions were determined using a modified Bradford assay
(Bio-Rad laboratories) while that of the insoluble tubulin fractions
were analyzed using BCA protein assay kit (Pierce) as described in
the manufacturer’s manual.
Cell Lysate Preparation for Total Tubulin (Containing
Soluble and Insoluble Fractions)
HCT 116 (76105) cells were grown on 60 mm plates and
incubated for 24 h before drug treatment. Cycloheximide (CHX)
was added as a protein synthesis inhibitor along with the
cinnamaldehydes and the treated cells were lysed in SDS lysis
buffer. Protein contents of the lysates were analyzed using BCA
protein assay kit.
BIAM Labeling Assay
Tubulin was labeled with BIAM to investigate direct interaction
of tubulin with cinnamaldehydes. Briefly, purified porcine brain
tubulin (4 mM) was incubated with either DMSO, CAC (100 mM),
or cinnamaldehydes (50 mM and 100 mM) at 37uC for 30 min in
0.1 M PIPES-KOH and 0.5 mM MgCl2 pH 7.5. After incuba-
tion, 5 ml aliquots were withdrawn from the samples and
incubated with 25 ml of freshly prepared 20 mM BIAM solution
in 0.1 M PIPES-KOH and 0.5 mM MgCl2 pH 6.5 at 37uC for
15 min. The reaction was quenched using freshly prepared
iodoacetamide solution (final concentration 50 mM). Protein
samples were subjected to SDS-PAGE and Western blotting with
HRP–conjugated streptavidin using enhanced chemiluminescence
system. Equal loading of protein was confirmed by immunoblot-
ting using anti-b-tubulin antibody.
Densitometric and Statistical Analysis
Image J software (NIH) was used for quantification of intensities
of western blot bands. Numerical data were presented as
mean6SD. Statistical significance between control and treatment
Representative immunofluorescence microscopic images of cells cultured on coverslips and treated or untreated with cinnamaldehyde analogs or
paclitaxel at indicated concentrations for 12 h. Following drug treatment, cells were fixed and probed with anti-phospho-histone H3 antibody
followed by Alexa Fluor 594-conjugated secondary antibodies, then counterstained with DAPI. Images were obtained at 406magnification. Lower
panel: Bar graphs depicting percentage of number of cells co-stained with DAPI and Alexa Fluor 594 in a total of 6 microscopic images taken from
random spots on each immunolabelled coverslips. Data points are means6SD of three independent experiments. *p,0.05 versus DMSO control.
doi:10.1371/journal.pone.0050125.g003
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groups was determined using Student’s t-test and values of p,0.05
were considered as statistically significant.
Results
Inhibitory Effects of Cinnamaldehydes on Proliferation
and Anchorage-independent Growth of HCT 116 and
MCF-7 Cells
FBCA is a ‘‘hybrid analog’’ of BCA and FHCA that contains
both the 2-benzoyloxy and 5-fluoro substituent (Fig. 1). Evaluation
of its antiproliferative activity against human colon-derived HCT
116 and mammary-derived MCF-7 carcinoma cells using MTT
cell viability assay revealed that FBCA expectedly displayed
cytotoxic potency around 7-fold greater than naturally occurring
CA (Table 1). In addition, FBCA exhibited anti-tumor potency
stronger than BCA and comparable to FHCA (Table 1, GI50 and
LC50 values for CA, BCA and FHCA were previously reported in
[20]; presented here for comparison with antiproliferative activity
of FBCA as determined in this study). BCA, FHCA and FBCA
also inhibited proliferation of MRC-5 lung fibroblasts with GI50
and LC50 values 2 to 10 fold greater than that obtained for the
more susceptible HCT 116 cell line. The growth-inhibitory
properties of selected cinnamaldehydes were investigated in
anchorage-independent cultures. Reduction in the number of cell
colonies of HCT 116 or MCF-7 cells upon treatment with
cinnamaldehydes was evaluated. A significant dose-dependent
decrease in the number of colonies was observed in cinnamalde-
hyde-treated wells as compared to DMSO control. Notably, BCA,
FHCA and FBCA required a much lower concentration than CA
to elicit a similar effect. The negative control CAC that is devoid of
the a,b-unsaturated carbonyl group did not show any reduction in
the number of colonies as compared to DMSO control (Fig. 2).
Induction of G2/M phase Arrest by Cinnamaldehydes
Cell cycle analyses were performed using flow cytometry to
examine if the cell cycle distribution profiles of HCT 116 cells
were affected by cinnamaldehydes as a manifestation of their
antiproliferative action. In general, DNA histograms of the
cinnamaldehyde-treated cells showed a profound increase in the
proportion of cells in G2/M phase at the 12 and 24 h timepoints
(Fig. 3a). For lethal concentrations (60 and 80 mM CA; 20 and
30 mM BCA; 10, 20 and 30 mM FHCA and FBCA), as time
progressed from 24 h to 36 h of drug exposure, the accumulated
G2/M population decreased, accompanied with an appearance of
cells in the sub G1 phase (Fig. 3a, 3b). Interestingly, although non-
lethal concentrations of the compounds (20 and 40 mM CA; 5 and
10 mM BCA; 5 mM FHCA and FBCA) also brought about arrest
of cells at G2/M phase at an earlier time of exposure (12 h), the
DNA histograms at a later time (36 h) were restored to a normal
cell cycle distribution. The inactive analog CAC produced no
observable effects on the cell cycle at all timepoints (Fig. 3a). To
determine whether cells were arrested in G2 and blocked from
entering mitosis or cells were arrested in M phase and prevented
from completing mitosis, lysates of HCT 116 cells treated with
cinnamaldehydes or paclitaxel at proapoptotic doses for 12 h were
analyzed by western blotting for levels of mitosis marker phospho-
histone H3. As shown in Fig. 3c, while cells treated with paclitaxel
(a prototypical microtubule targeting agent that arrests cells in M
phase) caused a sharp increase in phospho-histone H3, those
treated with cinnamaldehydes expressed comparable levels of
phospho-histone H3 as DMSO control. Similar results were
observed using immunofluorescence microscopy, where percent-
age of paclitaxel-treated cells stained by anti-phospho-histone H3
antibody was significantly increased (22.0% for paclitaxel versus
2.3% for DMSO control). In contrast, treatment with cinnamal-
dehydes did not increase the percentage of phospho-histone H3-
positive cells (Fig. 3d). These results therefore suggested that
cinnamaldehydes caused arrest of cells in G2 phase and cells were
prevented from entering mitosis.
Dysregulation of Cell Cycle Regulatory Proteins Mediated
by Proapoptotic Doses of Cinnamaldehydes
As cdk1 has been described as one of the master regulators of
mitosis [22], it was deduced that cinnamaldehydes might affect
G2/M phase progression through dysregulation of cdk1. For
investigation, a lethal concentration of cinnamaldehydes (80 mM
for CA, 30 mM for BCA, FHCA and FBCA) that led G2 arrested
HCT 116 cells to cell death was selected to examine the possible
effects on cdk1 in relation to induction of tumor cell death. It was
found that levels of phospho-cdk1 as well as total cdk1 declined in
a time-dependent manner; the decrease in total cdk1 was more
marked than that of the phosphorylated protein (Fig. 4). Densi-
tometric analysis of western blot bands from independent
experiments was performed; notably, for FHCA and FBCA, this
time-dependent decline was correlated to the onset of apoptosis
around 16 h, which was indicated by the appearance of cleaved
forms of caspase 3 (17 and 19 kDa) and PARP (89 kDa) (lower
panels of western blot analyses for each compound). For BCA and
naturally occurring CA, similar correlation of decline in phospho-
cdk1 and total cdk1 with emergence of cleaved PARP and caspase
3 was observed at 16 to 24 h of drug treatment. Following onset of
apoptosis, cellular events such as proteolysis would have taken
place as the cell progressed into late apoptosis, such that cleaved
forms of caspase 3 and PARP were further cleaved to smaller
peptide fragments. This might explain why at a late timepoint of
36 h, a decrease in the levels of cleaved PARP and caspase 3 was
observed for BCA, FHCA and FBCA (Fig. 4b–d). On this note, we
do not rule out the possibility that decline in levels of proteins at 24
to 36 h upon drug treatment could be a cellular consequence of
late apoptosis. In addition, as cyclin B1 is also involved in
regulating G2 to M transition [23], effects of cinnamaldehydes on
total and phosphorylated forms of this protein were also analyzed.
The levels of phospho-cyclin B1 and total cyclin B1 were found to
increase upon 3 h of cinnamaldehyde treatment, remained
elevated till 24 h, and declined by 36 h (Fig. 4). Consistent with
results presented in Fig. 3c and 3d, levels of phospho-histone H3
remained constant to levels at 0 h, until a mild decline was
observed at 24 and 36 h.
The dose-dependent effect of cinnamaldehydes on proteins
regulating the G2/M phase was also evaluated at two timepoints:
at 12 h where onset of apoptosis was triggered, and at 24 h where
late apoptosis had likely set in. As shown in Fig. 5, lethal doses of
Figure 4. Time-dependent effect of cinnamaldehydes on cdk1, cyclin B1, phospho-histone H3, and induction of apoptosis. HCT 116
cells treated with a proapoptotic dose of cinnamaldehydes were harvested at the indicated timepoints. Cell lysates were analyzed for cdk1, phospho-
cdk1, cyclin B1, phospho-cyclin B1, phospho-histone H3, caspase 3 (full length and cleaved) and PARP (full length and cleaved) using Western blot
analysis. Blots were probed for b-actin to ensure equal protein loading. Bottom panels of western blot analyses for each compound: densitometric
intensities of each protein normalized to that of each respective actin loading control. Results are presented as means6SD of at least two
independent experiments; SD denoted by error bars. Data points at timepoints within boxed region show p,0.05 versus timepoint = 0.
doi:10.1371/journal.pone.0050125.g004
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cinnamaldehydes decreased the levels of total cdk1 and phospho-
cdk1 (Tyr15), with the former declining more markedly as
compared to that of the latter. At these doses, levels of total
cdc25C as well as phospho-cdc25C (Ser216) also decreased.
Conversely, cyclin B1 levels were upregulated with a more
apparent increase at 24 h. Interestingly, at 12 h, the levels of
cyclin B1 in both untreated control and cinnamaldehyde-treated
cells were generally higher than those at 24 h. One proposed
Figure 5. Dose-dependent effect of (a) CA, (b) BCA, (c) FHCA and (d) FBCA on cell cycle regulatory proteins. HCT 116 cells were treated
with indicated concentrations of cinnamaldehydes for 12 h or 24 h. Cell lysates were analyzed by Western blotting for proteins controlling G2 to
mitosis transition (cdk1, phospho-cdk1, cdc25C, phospho-cdc25C, cyclin B1, phospho-cyclin B1), proteins regulating spindle assembly (mad2, cdc20,
survivin) and apoptotic markers (full length and cleaved) caspase 3, and (full length and cleaved) PARP. Blots were also probed for b-actin to ensure
equal protein loading.
doi:10.1371/journal.pone.0050125.g005
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plausible explanation could be that cells were in exponential
growth phase at 12 h of drug treatment. By 24 h, cells began to
exit out of exponential growth, which might contribute to lower
levels of cyclin B1. Nonetheless, it remains to be further
investigated why levels of cyclin B1, but not other cell cycle
proteins, produced more apparent differential levels of expression
between the two timepoints. Finally, levels of mad2, cdc20 and
survivin, the proteins that regulate proper alignment of sister
chromatids to the mitotic spindle, were found to be decreased at
these concentrations (Fig. 5a–d).
To exclude the possibility that decline in cell cycle regulatory
proteins was a result of early apoptosis that occurred around 12 to
16 h of cinnamaldehydes treatment, cells pretreated with 50 mM
pan caspase inhibitor Z-VAD-FMK for 1 h were treated with the
more cytotoxic analog FBCA for 12 h. Under the cellular
circumstances where apoptosis was blocked (evident from the
absence of cleaved PARP and caspase 3), decline in the levels of
total cdk1, phospho-cdk1, total cdc25C and phospho-cdc25C was
still apparent and concurred with levels observed in cells untreated
with Z-VAD-FMK (Fig. 6). The results therefore suggested that
loss of these cell cycle regulatory proteins was an effect of the drugs
and not a consequence of cell death.
Interaction of Tubulin with Cinnamaldehydes Leading to
Tubulin Aggregation
On the basis that a,b-unsaturated carbonyl compounds have
been demonstrated to display affinity for sulfhydryl groups in
tubulin [24], interaction of Michael acceptor-bearing cinnamal-
dehydes with tubulin was investigated using purified tubulin. After
incubation with cinnamaldehydes, tubulin samples were incubated
with BIAM, which would label free thiol groups in the protein.
Modification of thiol sites by cinnamaldehydes would render them
unavailable for BIAM labeling, observed as a reduction in the
intensities of bands probed with HRP-streptavidin. Indeed,
a marked decrease was observed in the band intensities of
cinnamaldehydes-treated samples as compared to DMSO control
while CAC failed to reduce labeling by BIAM (Fig. 7a). In
agreement with the antiproliferative activities, CA displayed
a weaker interaction with the sulfhydryl groups in tubulin as
compared to BCA, FHCA and FBCA. The possible effect of
cinnnamaldehydes binding to cellular tubulin was next investigat-
ed. HCT 116 cells treated with lethal concentrations of
cinnamaldehydes were immunolabelled for tubulin. Fluorescence
microscopic images revealed conspicuous tubulin aggregation and
loss of the interphase microtubular network (Fig. 7b). To further
examine the tubulin aggregation phenotype, we assessed the
distribution of soluble and insoluble tubulin upon drug treatment
by analyzing the soluble and insoluble cell lysate fractions. The
soluble fraction contained the dimeric a,b-tubulin while the
insoluble fraction contained the tubulin polymers and aggregates.
The results had agreed with the immunocytochemistry micro-
scopic observations; in cells that were exposed to cinnamaldehydes
for 16 h, a dose-dependent increase in the insoluble tubulin
content was observed along with depletion of tubulin in the soluble
fraction (left and middle panel of Fig. 8a). Densitometric analysis
of western blots obtained from independent experiments revealed
a statistical significant accumulation of insoluble tubulin normal-
ized to actin for cytotoxic concentrations of cinnamaldehydes that
Figure 6. Effect of FBCA on cell cycle regulatory proteins in cells pretreated with pan caspase inhibitor Z-VAD-FMK. HCT 116 cells
were treated or untreated with 50 mM Z-VAD-FMK for 1 h, followed by addition of FBCA at indicated concentrations for another 12 h. Cell lysates
were analyzed by Western blotting for proteins controlling G2 to mitosis transition (cdk1, phospho-cdk1, cdc25C, phospho-cdc25C, cyclin B1,
phospho-cyclin B1) and apoptotic markers (full length and cleaved) caspase 3, and (full length and cleaved) PARP. Blots were also probed for b-actin
to ensure equal protein loading.
doi:10.1371/journal.pone.0050125.g006
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were previously determined to progress G2/M arrested cells to cell
death (right panel of Fig. 8a). Decline in soluble tubulin had
appeared to be gradual in contrast to the marked increase in
insoluble tubulin. We reasoned that at equilibrium, cellular tubulin
largely existed in the soluble phase. As a result, relative to changes
in insoluble tubulin, changes in soluble tubulin content would be
marginally small and less significantly detected on western blots.
The possibility of cinnamaldehydes affecting tubulin degradation
was also examined. A time-chase experiment was performed in
which cells were treated with BCA alongside protein synthesis
inhibitor cycloheximide (CHX). Both CHX plus BCA-treated cells
and CHX only-treated cells did not display any changes in the
total tubulin content with respect to time, indicating that
degradation of tubulin was not affected by cinnamaldehydes
(Fig. 8b).
Discussion
Previous studies have reported anti-tumor properties of CA and
its analogs in mammalian cancer cell lines as well as in mouse
xenograft models [8,10–13,16–19]. Although the studies report
wide-ranging molecular effects of cinnamaldehydes, the precise
mechanisms by which cinnamaldehydes elicit their anti-cancer
properties remain obscure. It is believed that cinnamaldehydes
exert their anti-tumor effects via several mechanisms of action. In
a previous study conducted in our laboratory, BCA and FHCA
were identified as the lead analogs possessing potent antiprolifera-
tive activities; the enhancement in biological activity was
attributed to the electron withdrawing 2-benzoyloxy and 5-fluoro
substituent in BCA and FHCA respectively [20]. In this study, in
an attempt to derive a structural analog that would possess the
desirable characteristics of BCA and FHCA, a novel analog FBCA
that bears both 2-benzoyloxy and 5-fluoro substituents was
synthesized and evaluated along with BCA and FHCA. In the
MTT assay, FBCA expectedly demonstrated superior and
comparable anti-tumor properties against HCT 116 and MCF-7
cells as compared to BCA and FHCA respectively. Similarly, in
the soft agar assay, the superior antiproliferative activity of FBCA
was further demonstrated as a dose-dependent reduction in the
anchorage-independent growth of HCT 116 and MCF-7 cells.
The G2/M phase arrest brought about in HCT 116 cells upon
treatment with cinnamaldehydes at sub-lethal and lethal doses
culminated in a different cellular outcome. For the lethal
concentrations used, as time progressed, the G2/M cell population
declined with a corresponding increase in the sub G1 population,
Figure 7. Interaction of cinnamaldehydes with sulfhydryl groups in tubulin and their effects on tubulin organization in HCT 116
cells. (a) Cinnamaldehydes were incubated with purified tubulin for 30 min at 37uC and aliquots of samples were labeled with BIAM. Western
blotting by HRP-streptavidin was performed to detect BIAM labeling of free thiol groups. Equal amount of tubulin across all samples was ascertained
by probing for b-tubulin. (b) Representative immunofluorescence microscopic images of cells treated with DMSO (i & ii), 30 mM BCA (iii & iv), 30 mM
FHCA (v & vi), and 30 mM FBCA (vii & viii). Cells cultured on coverslips and treated with DMSO or cinnamaldehydes for 8 h were fixed, and subjected
to immunocytochemical analysis using anti-b-tubulin antibody. Coverslips were then mounted on slides using mounting medium containing DAPI
and images were obtained at 1006magnification.
doi:10.1371/journal.pone.0050125.g007
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whose appearance would indicate that the G2/M arrested cells
proceeded to cell death. The lethal doses failed to increase levels of
mitosis marker phospho-histone H3, indicating that cinnamalde-
hydes arrested cells at G2 phase and not the M phase. On the
other hand, the sub-lethal concentrations caused a transient arrest
of cells at G2/M phase, which decreased at a later timepoint (36 h)
with the restoration of a normal cell cycle distribution. The lack of
appearance of the sub G1 cell population indicated that the cells
survived the episode of drug insult, likely to be through activation
of cellular repair mechanisms to relieve the cells out of G2/M
phase arrest.
Examination of the effect of cinnamaldehydes on the cell cycle
regulatory proteins responsible for controlling G2 to mitosis
transition and mitotic spindle formation had found a drug-
mediated dose- and time-dependent decline in the levels of
phospho-cdk1 and total cdk1, as well as a dose-dependent increase
in the levels of phospho-cyclin B1 and total cyclin B1. The total
cdk1 levels showed a more pronounced decline than the phospho-
cdk1 (Tyr15), indicating that cinnamaldehyde-treated cells might
Figure 8. Cinnamaldehydes cause dose-dependent accumulation of insoluble tubulin. (a) HCT 116 cells were treated with
cinnamaldehydes at indicated concentrations for 16 h. Soluble (left panel) and insoluble (middle panel) fractions of collected cell lysates were
analyzed by Western blotting with anti-b-tubulin antibody. (b) HCT 116 cells were treated with 40 mM cycloheximide (CHX) alone or 30 mM
BCA+40 mM CHX and lysates containing both soluble and insoluble tubulin were collected at indicated timepoints. Total tubulin in the lysates was
analyzed by western blotting with anti-b-tubulin antibody. Blots were probed for b-actin to ensure equal protein loading. Right panel of (a): band
intensities quantified by densitometry and normalized to respective actin loading were expressed as percentage of insoluble tubulin per total tubulin.
Right panel of (b): band intensities were quantified by densitometry and normalized to respective actin loading control. Results are presented as
means6SD of at least two independent experiments; SD denoted by error bars. Statistically significant (p,0.05 versus DMSO control) data points
were boxed.
doi:10.1371/journal.pone.0050125.g008
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contain a net increase in the phosphorylated form of cdk1 as
compared to the control cells. An accumulation of cyclin B1 had
resulted, while total cdc25C and phospho-cdc25C (Ser216), which
is upstream of cdk1 in the activation cascade, were dose-
dependently down-regulated in response to drug treatment. As
cdc25C dephosphorylates the inactive phospho-cdk1 into the
active cdk1 [25], a reduction in the levels of cdc25C would likely
explain the higher levels of phospho-cdk1. Western blot analyses
showed that the appearance of cleaved forms of caspase 3 and
PARP was concomitant with cdk1 down-regulation. As the role of
cdk1 is essential throughout mitosis, we construed that blocking
cdk1 activation by cinnamaldehydes had in part led to the arrest of
cells at G2 phase. Cyclin B1 complexes with cdk1 and during late
G2 phase, and activation of the cdk1/cyclin B1 complex through
cdc25C-dependent dephosphorylation of phospho-cdk1 and
phosphorylation of cyclin B1 triggers cells to enter mitosis [24].
Cinnamaldehydes had caused accumulation of cyclin B1, which
was not coupled with accumulation of non-phosphorylated cdk1.
Thus, it was deduced that cdk1/cyclin B1 complexes failed to be
activated; cells in G2 phase were prevented from entering mitosis,
which eventually triggered apoptotic cell death.
Formation of the microtubular mitotic spindle is crucial in
mitosis for proper segregation of chromosomes [4]. Cells check for
unattached chromosomes or any damages to the spindle before
proceeding to anaphase and activate the spindle assembly
checkpoint if any misalignment or improper attachment is
detected [26]. We had examined the levels of proteins regulating
spindle assembly such as mad2, cdc20 and survivin. Cdc20 is a co-
factor for the ubiquitin ligase APC/C which degrades proteins like
cyclin B and securin to allow the cell to proceed into anaphase.
However, in case of misalignment or improper spindle formation,
cdc20 is inhibited by proteins such as mad2 to allow for
appropriate alignment [27]. Survivin is a member of the inhibitor
of apoptosis (IAP) family, and has dual roles in mitosis and
apoptosis. Expression of survivin increases during mitosis where it
associates with microtubules [28]. It also acts as an inhibitor of
apoptosis and its expression has been associated with aggressive
tumors [29]. Down-regulation of survivin is therefore considered
as a potential strategy for cancer therapy [30]. Upon treatment
with cinnamaldehydes, both mad2 and cdc20 were depleted at the
lethal concentrations. Survivin levels also declined at these
concentrations of cinnamaldehydes, thus weakening the anti-
apoptotic machinery and rendering the cells more susceptible to
apoptosis. Again, it was noted that apoptosis, as detected by
appearance of cleaved caspase 3 and cleaved PARP, concurred
with the doses at which the cell cycle regulatory proteins were
altered. This had indicated that the induction of apoptosis was
associated with dysregulation of cell cycle regulatory proteins.
Microtubules are cytoskeletal components that are composed of
a- and b-tubulin heterodimers, of which a number of isotypes of
the human a and b protein exist. Microtubules and their tightly
regulated polymerization dynamics during mitosis are targets for
microtubule-targeting agents (MTAs) [31]. The MTAs such as
taxanes (paclitaxel and docetaxel) and Vinca alkaloids (vincristine
and vinblastine) arrest cells at M phase by direct binding to
microtubules to disrupt microtubule dynamics [6,7]. In recent
years, compounds of diversified structures are discovered to target
tubulin or microtubules with different mechanisms of action. For
example, peroxisome proliferator-activated receptor c (PPAR-c)
inhibitors are found to reduce tubulin levels likely through
proteasomal degradation without affecting microtubule polymer-
ization or dynamics [32,33]. On the other hand, isothiocyanates
(ITCs) are found to cause formation of tubulin aggregates through
direct binding to cysteine residues in tubulin, followed by tubulin
degradation in a proteasomal-dependent manner [34]. We had
found that cinnamaldehydes did not alter the tubulin polymeri-
zation kinetics in vitro (data not shown), suggesting the possible
involvement of other cellular machinery. Consistent with work by
Ishiguro et al. that reported the reaction of a,b-unsaturated
carbonyl compounds with sulfhydryls of tubulin [22], we found
in vitro evidence that cinnamaldehydes containing a,b-unsaturated
carbonyl groups interacted with tubulin protein. The interaction
had likely led to the tubulin aggregation phenotype as observed
using immunofluorescence microscopy. These tubulin aggregates
contributed to dose-dependent accumulation of insoluble tubulin.
However, tubulin degradation was not affected, indicating that
cinnamaldehydes appeared to be targeting tubulin with a mecha-
nism of action distinct from the current MTAs. The imbalanced
levels of soluble and insoluble tubulin might have halted proper
microtubule polymerization dynamics. This could at least in part
contribute to blockade of cells to enter M phase, thus leading to
a G2 arrest.
To conclude, in this study, CA and its analogs (BCA, FHCA ad
FBCA) with superior antiproliferative activities were found to
cause reduction in levels of cell cycle proteins such as cdk1,
cdc25C, mad2, cdc20 and survivin, elevation in levels of cyclin B1,
and aggregation of tubulin. Decline in cdk1 and cdc25C levels, as
well as tubulin aggregation contributed at least in part to arresting
cinnamaldehyde-treated cells in G2 phase, which led to apoptotic
cell death (summarized in Fig. 9). As cells were prevented from
entering mitosis, dysregulation of levels of spindle assembly
regulatory proteins mad2, cdc20 and survivin, which would result
in defective mitotic spindle formation, could not have taken place.
Thus, it is unlikely that depletion of these proteins regulating
Figure 9. Schematic summary of the proposed cellular out-
comes resulting from treatment with lethal concentrations of
cinnamaldehydes. A lethal dose of cinnamaldehydes resulted in G2
arrest associated with down-regulation of cell cycle regulatory proteins
cdk1 and cdc25C and tubulin aggregation, which prevented arrested
cells from entering into M phase. This finally led to apoptosis.
doi:10.1371/journal.pone.0050125.g009
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spindle assembly accounts for cinnamaldehyde-induced cell death.
Generally, it is believed that multiple molecular targets underscore
the antiproliferative activities of cinnamaldehydes. While ongoing
work continues to map out the precise network of mechanisms of
anti-tumor action of this class of compounds, this study had
produced experimental findings supporting the notion that
cinnamaldehydes induced G2 arrest and cell death that was at
least in part associated with tubulin targeting and reduction in
levels of cell cycle regulatory proteins like cdk1 and cdc25C. Given
that cell cycle proteins and tubulin are essential for all cells,
particularly proliferative cells, cinnamaldehydes may exert toxi-
cities on normal cells. Indeed, we had observed antiproliferative
effects of these analogs on normal lung MRC-5 fibroblasts with
potencies 2 to 10 times lower than that on the susceptible HCT
116 cell line. Therefore, development of analogs that show
preferential action on cell cycle reglulatory proteins and tubulin in
tumor cells and/or screening of selective sensitivity of these
proteins in tumors of individual patients are warranted for the
potential clinical application of this chemical class of compounds.
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